Skip to main content
. Author manuscript; available in PMC: 2020 Dec 18.
Published in final edited form as: Biochem J. 2020 Oct 16;477(19):3851–3866. doi: 10.1042/BCJ20190776

Figure 6. TRV-based silencing of ShNPSN11 leads to enhanced susceptibility to On-lz.

Figure 6.

(A) Phenotypes of TRV2 (CK; control) expression in LA1777. (B) Phenotype of TRV2:SlPDS expression in LA1777. (C) LA1777 + TRV2 (control) silenced plant 7-days-post-inoculation with On-lz. (D) LA1777 + TRV2:ShNPSN11-silenced plant 7-days-post-inoculation with On-lz. (E) LA1777 + TRV2 (control) silenced plant 14-days-post-inoculation with On-lz. (F) LA1777 + TRV2:ShNPSN11-silenced plant 14-days-post-inoculation with On-lz. (G) Real-time PCR quantification of ShNPSN11 mRNA accumulation, post-silencing, at 14-days-post-inoculation with control (TRV2) and TRV2:ShNPSN11. (H) Quantification of disease in LA1777 + TRV2:ShNPSN11-silenced plants at 7- and 14-days-post-inoculation with On-lz. The asterisk indicates statistically significant differences in disease index between untreated (CK) and TRV2 plants.